Physician

Alexandra Rose Paul, M.D.

According to 2025 Medicare claims, Alexandra Paul, M.D. (NPI: 1154659506) practices neurosurgery in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Albany, NY. This provider's primary affiliated billing organization is ALBANY MEDICAL COLLEGE (NPI: 1497921688; TIN: 141338310) and primary practice location at 12208-3478.

Paul's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 301 traditional Medicare patients, billed 614 HCPCS/CPT codes, and received $96,612 in Medicare payments. The top billing code was 36224 (Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist). Part D data shows 36 prescription claims across 18 beneficiaries totaling $2,220 in drug costs, led by Clopidogrel (Clopidogrel Bisulfate). Open Payments data shows 34 records totaling $18,080. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $28,689 to $96,612. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,041 and ending at $2,220. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$55K$110K2018 Medicare payment: $28,689 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $79,961 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $67,662 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $82,817 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $109,964 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $107,081 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $96,612 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
201867223$28,689
2019150471$79,961
2020124384$67,662
2021160409$82,817
2022257573$109,964
2023325676$107,081
2024301614$96,612

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.5K$5.0K2015 Drug cost: $1,041 (USD; Tot_Drug_Cst)2016 Drug cost: $1,056 (USD; Tot_Drug_Cst)2017 Drug cost: $4,212 (USD; Tot_Drug_Cst)2018 Drug cost: $1,513 (USD; Tot_Drug_Cst)2019 Drug cost: $4,817 (USD; Tot_Drug_Cst)2021 Drug cost: $2,353 (USD; Tot_Drug_Cst)2022 Drug cost: $5,020 (USD; Tot_Drug_Cst)2023 Drug cost: $4,710 (USD; Tot_Drug_Cst)2024 Drug cost: $2,220 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R18$1,041
20162436$1,056
20171322$4,212
20181217$1,513
2019N/R17$4,817
2020N/RN/RN/R
2021N/R20$2,353
20221327$5,020
20231835$4,710
20241836$2,220

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
36224Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist1617$221
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes8184$96
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more4040$92
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more95100$68
99231Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes63131$37

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ClopidogrelClopidogrel Bisulfate11810$106

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.30$4,543Medtronic, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.4$13,538MicroVention, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexandra Rose Paul, M.D.?

Tedicare shows public-source Medicare data for Alexandra Rose Paul, M.D. (NPI 1154659506), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexandra Rose Paul, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexandra Rose Paul, M.D.?

Alexandra Rose Paul, M.D. is linked to ALBANY MEDICAL COLLEGE (billing NPI 1497921688) in the available physician profile data.

Does Alexandra Rose Paul, M.D. have Open Payments data?

Alexandra Rose Paul, M.D. has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.